Ms. Rosenberg’s experience covers the spectrum from early-stage to Fortune 500 companies, including work in biopharmaceuticals, digital health, medtech, and generics manufacturers. She has developed brand strategies and marketing plans for 10+ multibillion-dollar products in retail and hospital environments, from proof of concept through launch, commercialization, and lifecycle management.

Ms. Rosenberg’s client work includes redesigning the commercial footprint of a biopharma marketing and sales model at two-thirds of the cost without negative revenue impact; more than doubling market share for a lagging respiratory product; uncovering $200+ million in revenue opportunities in a generics portfolio for a top industry player; crafting strategies for mature brands portfolios and securing investment for implementation; and leading a business and cultural transformation for a mid-size pharmaceutical company that achieved $200 million in cost savings while sustaining key brand sales.

Prior to joining A&M, Ms. Rosenberg was an experienced operator and investor with hands-on leadership in early-stage ventures across healthcare and higher education, notably spearheading revenue generation for a Series A healthtech company. Previously, she was a Partner at McKinsey & Company in the Pharmaceuticals and Medical Devices practice and co-founded the firm’s Digital Healthcare practice.

Ms. Rosenberg earned a bachelor’s degree in economics from Barnard College at Columbia University, where she currently serves as an adjunct faculty member in economics, and a PhD in economics from the University of Chicago. She is also an active angel investor in early-stage medtech, biotech, and digital health ventures.